Corporate Grants: Cancer - Onyx Pharmaceuticals

Description: Onyx Pharmaceuticals is committed to developing therapeutics that improve the lives of individuals with cancer. Our lead product is Nexavar® (sorafenib) tablets, an oral, targeted therapy for the treatment of patients with liver cancer and advanced kidney cancer.

Keywords: Onyx Pharmaceuticals, biopharmaceutical company, cancer therapeutics, Nexavar, sorafenib, ONX 0801, ONX 0803, ONX 0805, oral targeted therapy, liver cancer treatment, advanced kidney cancer treatment, liver cancer, kidney cancer, non-small cell lung cancer, breast cancer, ovarian cancer, colorectal cancer, cell cycle kinase inhibitor

Tags: onyxpharm, cancer, grant, onyx, corporate, pharmaceuticals, grants, guidelines, request, design, website, use, submit, terms, onx, kidney, liver, overview, treatment, sorafenib, education, cell, patients, therapy, targeted, advanced, oral, therapeutics, nexavar, patient, committed, improve, lives,

Onyxpharm.com

Content Revalency: Title: 100.00%   Description: 31.25%   Keywords: 46.15%  |  Document size: 17,248 bytes More info: Whois - Trace Route - RBL Check

ONYXPHARM.COM - Site Location
Country/Flag	United States
City/Region/Zip Code	Baltimore, Maryland, 21224
Organization	Edge Hosting, LLC
Internet Service Provider	Edge Hosting, LLC